Skip to main content
Signal8

O'Keefe Kenneth W

SEC insider (Form 3/4/5 filer). CIK 0001397661. Director at Jazz Pharmaceuticals plc (JAZZ). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2025. Located in DUBLIN 4, L2.

Companies O'Keefe Kenneth W has filed insider reports for

  • Jazz Pharmaceuticals plc (JAZZ): Director
O'Keefe Kenneth W profile photo

O'Keefe Kenneth W

CIK: 0001397661

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jazz Pharmaceuticals plc logo
JAZZ

Jazz Pharmaceuticals plc

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Dec 2, 2025
    Tax Payment
    Direct
    603 shares at avg. $173.07$104K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 8, 2025
    Tax Payment
    Direct
    1.8K shares at avg. $111.25$201K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 7, 2025
    Award
    Direct
    3.5K shares-

1-3 of 3